Guilin Pharmaceutical (Shanghai) Co., Ltd. China (Mainland)

We are Guilin Pharmaceutical (Shanghai) Co., Ltd. We develop, produce and market various kinds of generic drugs, specializing in antimalarial, anti-infective and antipyretic. We focus on drug markets in developing countries, and supply our products to various clients all over the world, such as WHO, UNICEF, ICRC, MSF, as well as other governmental, profit and non-profit organizations. Our goods have passed China GMP inspection, and we have products and workshops prequalified for WHO Prequalification program. In addition, our workshops and operations have been inspected by drug authorities from many countries, as well as quality auditors from profit and non-profit organizations. All activities are performed in an environment in compliance with international quality standards. At present, we are building a new manufacturing site in line with US FDA cGMP standards, which also maintains a balanced response to EU cGMP/ WHO GMP standards. The production capacity of over 15 billion tablets/capsules per year will meet the needs for further development for the domestic and global markets. In addition, we can provide such active pharmaceutical ingredients as levamisole and bumetanide.